Serum-Therapie rheumatischer Erkrankungen. Behandlung von Wirbelsäulen-Syndromen und degenerativen Gelenkerkrankungen mit organspezifischen Antikörpern

Author(s): Dudeck, J., Schwann, H., Klein, G.

Journal/Book: Therapiewoche. 1986; 36: 2206-2214.

Abstract: During investigations, carried out to find other methods of treatment, for rheumatic disorders, the therapeutic efficiency of Organ serum JOINT (anti-jointserum) was tested in 100 patients using a randomized doubleblind study. Treatment was based an 10 intracutaneous injections in the dose range between 0.1 and 0.3 ml, which were given into the acupuncture sites recommended by the manufacturer. Throughout the treatment period records were kept of changes in various qualities of pain, muscular tension and different laboratory Parameters including immunoglobulins. Statistical evaluation revealed immediately after termination of treatment no marked differences between the joint and control sera. A superior effectiveness of the joint serum could only be established for pain at rest.Both serum groups, however, showed significantly higher improvement rates as compared to the NaCl group, where treatment was based an physiotherapy alone. Inquiries made by letter after 3 months were answered by a total of 54 patients which were regarded as a representative Sample population with respect to their distribution over the various groups. It was interesting to note that 76% of the patients from the joint serum group now reported to experience sustained relief from pain, whereas the percentage of favourable results in the control serum group had dropped to 33%, thus being similar to that established in the Saline group. The mechanism of action of serum therapy is still obscure and immunological factors should possibly also be taken into account here.

Keyword(s): Organ-Serum Gelenk

Zurück | Weiter